Pamela Connealy
Equibles does not estimate personal net worth.
Get an email with a short summary when Pyxis Oncology, Inc. publishes a filing, an earnings call transcript or a press release.
Get PYXS alertsAbout Pamela Connealy
Pamela Connealy is recorded as COO at Pyxis Oncology, Inc. (PYXS) since March 22, 2023. Pyxis Oncology, Inc. reported in an 8-K filed July 3, 2025 that Pamela Connealy retired as Chief Financial Officer and Chief Operating Officer, effective July 1, 2025. Pyxis Oncology, Inc. reported in an 8-K filed July 3, 2025 that Pamela Connealy retired as Chief Financial Officer and Chief Operating Officer, effective July 1, 2025. Pyxis Oncology, Inc. reported in an 8-K filed March 22, 2023 that Pamela Connealy was appointed Chief Financial Officer and Chief Operating Officer, effective March 22, 2023. The proxy statement of Pyxis Oncology, Inc. reports total compensation of $1,425,237 for Pamela Connealy in fiscal 2025, including a base salary of $262,796. Disclosed compensation is on record for 5 fiscal years. Pyxis Oncology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Pyxis Oncology, Inc. includes Thomas Civik (CEO, Chairman and Board Member), Jitendra Wadhane (Chief Accounting Officer), Jakob Dupont, M.D. (Board Member) and 3 others.
“On July 1, 2025, Pamela Connealy, the Chief Financial Officer and Chief Operating Officer of Pyxis Oncology, Inc. (the "Company"), retired from the Company.”
“On July 1, 2025, Pamela Connealy, the Chief Financial Officer and Chief Operating Officer of Pyxis Oncology, Inc. (the "Company"), retired from the Company.”
Affiliation history
-
Current
2023-03-22–present
-
Start not stated–2025-07-01
Company network
Leadership on record at Pyxis Oncology, Inc.
- Thomas Civik CEO, Chairman, Board Member
- Jitendra Wadhane Chief Accounting Officer
- Jakob Dupont, M.D. Board Member
- Michael A. Metzger Board Member
- Rachel Humphrey, M.D. Board Member
- Santhosh Palani, Ph.D., CFA Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Pyxis Oncology, Inc. (PYXS) | Former Chief Financial Officer and Chief Operating Officer | $262,796 | $1,425,237 |
| 2024 | Pyxis Oncology, Inc. (PYXS) | Chief Financial Officer and Chief Operating Officer | $504,000 | $2,571,039 |
| 2023 | Pyxis Oncology, Inc. (PYXS) | Chief Financial Officer and Chief Operating Officer | $473,000 | $1,821,359 |
| 2022 | Pyxis Oncology, Inc. (PYXS) | Chief Financial Officer and Chief Operating Officer | $430,000 | $2,026,612 |
| 2021 | Pyxis Oncology, Inc. (PYXS) | Chief Financial Officer and Chief Operating Officer | $195,453 | $2,735,364 |